Literature DB >> 20691971

Elevated serum lipoprotein(a) as a potential predictor for combined intracranial and extracranial artery stenosis in patients with ischemic stroke.

B S Kim1, H S Jung, O Y Bang, C S Chung, K H Lee, G M Kim.   

Abstract

OBJECTIVES: Despite compelling evidence of lipoprotein(a) [Lp(a)] as a risk factor for ischemic stroke, its underlying mechanism remains unclear. Our aim is to investigate whether serum Lp(a) level is associated with the extent and location of cerebral steno-occlusive lesions, and with large artery atherosclerotic (LAA) stroke in Korean patients.
METHODS: We analyzed data prospectively collected over a 3-year period on consecutive patients with stroke or TIA. Based on an angiographic study, a total of 1012 patients were classified into four subtypes: non-cerebral stenosis (n=654), intracranial stenosis (n=198), extracranial carotid stenosis (n=86), and combined intracranial and extracranial carotid stenosis (n=74). Independent associations of Lp(a) levels with the extent and location of cerebral stenosis were evaluated, and Lp(a) levels of subtypes by the TOAST criteria were compared.
RESULTS: Lp(a) levels of LAA stroke were significantly higher than those of the other four stroke mechanisms. Patients with more advanced intracranial (p=0.001) and extracranial carotid stenoses (p=0.001) tended to have higher Lp(a) levels. In multiple regression analysis, the third Lp(a) quartile was the strongest risk factor for isolated intracranial (OR 3.36, 95% CI 1.77-6.37) or extracranial stenosis (OR 4.82, 95% CI 1.96-11.88), whereas the fourth Lp(a) quartile was the most powerful predictor for combined intracranial and extracranial carotid stenosis (OR 4.98, 95% CI 1.92-12.91).
CONCLUSIONS: Our results indicate that greatly elevated Lp(a) levels are associated with LAA stroke and extensive burden of cervicocerebral steno-occlusive lesions, which might offer indirect evidence of proatherothrombogenic role of Lp(a) in ischemic stroke.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20691971     DOI: 10.1016/j.atherosclerosis.2010.07.007

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  16 in total

1.  Lipoprotein (a) as a Predictor of Early Stroke Recurrence in Acute Ischemic Stroke.

Authors:  Xiao-Wu Hong; Dong-Mei Wu; Jun Lu; Yuan-Lin Zheng; Wen-Jun Tu; Jing Yan
Journal:  Mol Neurobiol       Date:  2016-12-21       Impact factor: 5.590

2.  Treatment of risk factors to prevent stroke.

Authors:  Junya Aoki; Ken Uchino
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

3.  Predictive value of lipoprotein(a) for assessing the prevalence and severity of lower-extremity peripheral artery disease among patients with acute coronary syndrome.

Authors:  Ryo Okubo; Rine Nakanishi; Yousuke Oka; Yoshimasa Kojima; Shingo Matsumoto; Hiroto Aikawa; Ryota Noike; Takayuki Yabe; Hideo Amano; Mikihito Toda; Takanori Ikeda
Journal:  Heart Vessels       Date:  2022-09-06       Impact factor: 1.814

4.  Utility of Serum Growth Arrest-Specific Protein 6 as a Biomarker of Severity and Prognosis After Severe Traumatic Brain Injury: A Prospective Observational Study.

Authors:  Bu-Kao Ni; Jian-Yong Cai; Xiao-Bo Wang; Qun Lin; Xue-Na Zhang; Jian-Hua Wu
Journal:  Neuropsychiatr Dis Treat       Date:  2022-07-14       Impact factor: 2.989

5.  The relationship between serum lipoprotein (a) levels and ischemic stroke risk: a cohort study in the Chinese population.

Authors:  Shao-yi Li; Yun Gao; Wei-ning Ma; Hua-chao Wang; Gang Zhou; Wen-chang Guo; Yun-hui Liu
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

6.  Association between non-high-density-lipoprotein-cholesterol levels and the prevalence of asymptomatic intracranial arterial stenosis.

Authors:  Jianwei Wu; Qian Zhang; Huajun Yang; Xiang Gao; Yong Zhou; Anxin Wang; Chunxue Wang; Shufeng Zhang; Shouling Wu; Xingquan Zhao
Journal:  PLoS One       Date:  2013-05-29       Impact factor: 3.240

7.  The I405V and Taq1B polymorphisms of the CETP gene differentially affect sub-clinical carotid atherosclerosis.

Authors:  Eliane Soler Parra; Natália Baratella Panzoldo; Denise Kaplan; Helena Coutinho Franco de Oliveira; José Ernesto dos Santos; Luiz Sérgio Fernandes de Carvalho; Andrei Carvalho Sposito; Magnus Gidlund; Ruy Tsutomu Nakamura; Vanessa Helena de Souza Zago; Edna Regina Nakandakare; Eder Carlos Rocha Quintão; Eliana Cotta de Faria
Journal:  Lipids Health Dis       Date:  2012-10-05       Impact factor: 3.876

Review 8.  Biomarkers for stroke.

Authors:  Suk Jae Kim; Gyeong Joon Moon; Oh Young Bang
Journal:  J Stroke       Date:  2013-01-31       Impact factor: 6.967

9.  Elevated plasma total cholesterol level is associated with the risk of asymptomatic intracranial arterial stenosis.

Authors:  Yuan Shen; Jing Wang; Jianwei Wu; Weikai Qu; Chunxue Wang; Xiang Gao; Yong Zhou; Anxin Wang; Shouling Wu; Xingquan Zhao
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

10.  Prevalence and risk factors of intracranial and extracranial artery stenosis in asymptomatic rural residents of 13 villages in China.

Authors:  Haiqiang Jin; Qing Peng; Ding Nan; Pu Lv; Ran Liu; Wei Sun; Yuming Teng; Yuanyuan Liu; Chenghe Fan; Haiying Xing; Ke Xu; Yining Huang
Journal:  BMC Neurol       Date:  2017-07-18       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.